The last time I took a look at Chipolte (CMG) was late December (here) as the company’s e.coli / norovirus crisis was emerging. The stock had declined from its all time highs made in August 2015 …
Continue readingCMG
Last night on CNBC’s Fast Money we had a short little debate on how to properly assign an earnings multiple to a once highflying growth darling like Chipolte (CMG), once disaster hits. As I detailed …
Continue reading
Regular readers of Risk Reversal know that we are tried and true believers in technical analysis, despite rarely starting an idea with a chart, more commonly using charts as an input to an existing thesis. …
Continue reading
Yesterday, I got a question from a long time reader Russell who asked my thoughts on his inclination to play Panera Bread (PNRA) from the long side as a potential beneficiary of Chipolte’s (CMG) e-coli …
Continue reading
Here is a quick recap of trades that we initiated, closed, or debated in the week that was July 27th – July 31st:
Continue reading
Here is a quick recap of trades that we initiated, closed, or debated in the week that was July 20th – July 24th:
Continue reading
THIS: AND THIS: ARE VERY DIFFERENT THAN THIS: AND THIS: GOOGL’s one day market cap gain last Friday of about$60 billion was equal to more than the combined market capitalization’s of FTNT & NFLX (even after their …
Continue reading
Last week when CMG was $654 we placed an bearish leaning trade (read here) targeting a disappointment on their upcoming Q2 results. We closed the position for a small loss (read here) as we did not …
Continue reading
A week ago we looked to fade the bounce off the 600 level in CMG into its earnings event and target that level for a re-test. We wanted minimize the premium out-layed as this is …
Continue reading
A week ago, following Barron’s negative article on Chipolte (CMG), we took a look at the stock (below) and agreed with the fundamental take, but concluded: it kind of feels like a press on the …
Continue reading